Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
317.5 INR | +2.12% | +3.50% | +27.28% |
05-13 | Biocon Signs Deal with Medix for Commercialization of Chronic Weight Management Drug in Mexico | MT |
04-30 | Natural Biocon (India) CFO Passes Away | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.28% | 4.45B | |
+5.33% | 111B | |
+12.11% | 106B | |
-12.56% | 22.24B | |
-3.70% | 21.25B | |
-6.03% | 18.97B | |
-35.21% | 18.52B | |
-10.86% | 16.81B | |
+5.10% | 13.94B | |
+37.57% | 12.54B |
- Stock Market
- Equities
- BIOCON Stock
- News Biocon Limited
- Biocon Begins Phase-2 Clinical Trial of Itolizumab for Ulcerative Colitis